Financial News

Prothena Plummets 60% After Lead Drug Fails Phase 2 Trial

By: via Benzinga
Prothena Corporation PLC (NASDAQ: PRTA) plummeted 60 percent Monday morning after a disappointing update relating to the company's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback